Literature DB >> 15550266

The WHO dose pole for the administration of praziquantel is also accurate in non-African populations.

A Montresor1, P Odermatt, S Muth, F Iwata, Y A Raja'a, A M Assis, A Zulkifli, N B Kabatereine, A Fenwick, S Al-Awaidy, H Allen, D Engels, L Savioli.   

Abstract

In 2001, WHO developed a pole for the administration of praziquantel without the use of weighing scales, with encouraging results in African populations. In the present study, the pole was tested on height/weight data from 9354 individuals from 11 non-African countries. In more than 98% of the individuals (95% CI 97.8-98.4) the pole estimated an acceptable dosage (30-60 mg/kg), a performance statistically similar to that observed in African populations. Reproducing the present pole in the form of a strip of paper and including it in each container of praziquantel would greatly facilitate the administration of the drug in large-scale interventions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15550266      PMCID: PMC5628732          DOI: 10.1016/j.trstmh.2004.06.006

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  5 in total

1.  Alternatives to bodyweight for estimating the dose of praziquantel needed to treat schistosomiasis.

Authors:  A Hall; C Nokes; S T Wen; S Adjei; C Kihamia; L Mwanri; E Bobrow; J de Graft-Johnson; D Bundy
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 Nov-Dec       Impact factor: 2.184

2.  Development and validation of a 'tablet pole' for the administration of praziquantel in sub-Saharan Africa.

Authors:  A Montresor; D Engels; L Chitsulo; D A Bundy; S Brooker; L Savioli
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Sep-Oct       Impact factor: 2.184

3.  Prevention and control of schistosomiasis and soil-transmitted helminthiasis.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2002

4.  Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium.

Authors:  P Taylor; H M Murare; K Manomano
Journal:  J Trop Med Hyg       Date:  1988-02

5.  High-dose praziquantel for neurocysticercosis: efficacy and tolerability.

Authors:  P R Bittencourt; C M Gracia; A M Gorz; S Mazer; T V Oliveira
Journal:  Eur Neurol       Date:  1990       Impact factor: 1.710

  5 in total
  15 in total

1.  Negative Association of Interleukin-33 Plasma Levels and Schistosomiasis Infection in a Site of Polyparasitism in Rural Cameroon.

Authors:  Severin Donald Kamdem; Francis Konhawa; Erve Martial Kuemkon; Leonel Meyo Kamguia; Gladys K Tchanana; Frungwa Nche; Alim Oumarou; Mamadou Hamza; Yasmine Ouratou; Mariette Nzoku Tcheutchoua; René Ghislain Essomba; Marie Paule Ngogang; Michel Kengne; Palmer Masumbe Netongo; Bienvenu Etogo Ondigui; Marie Claire Okomo Assoumou; Frank Brombacher; Justin Komguep Nono
Journal:  Front Immunol       Date:  2019-12-03       Impact factor: 7.561

Review 2.  Epidemiology, of bilharzias (schistosomiasis) in Uganda from 1902 until 2005.

Authors:  I Odongo Aginya Emmanuel; Doehring Ekkehard
Journal:  Afr Health Sci       Date:  2008-12       Impact factor: 0.927

3.  Schistosoma mansoni infection induces plasmablast and plasma cell death in the bone marrow and accelerates the decline of host vaccine responses.

Authors:  Fungai Musaigwa; Severin Donald Kamdem; Thabo Mpotje; Paballo Mosala; Nada Abdel Aziz; De'Broski R Herbert; Frank Brombacher; Justin Komguep Nono
Journal:  PLoS Pathog       Date:  2022-02-14       Impact factor: 6.823

4.  Treatment of intestinal schistosomiasis in Ugandan preschool children: best diagnosis, treatment efficacy and side-effects, and an extended praziquantel dosing pole.

Authors:  José Carlos Sousa-Figueiredo; Joyce Pleasant; Matthew Day; Martha Betson; David Rollinson; Antonio Montresor; Francis Kazibwe; Narcis B Kabatereine; J Russell Stothard
Journal:  Int Health       Date:  2010-06       Impact factor: 2.473

5.  Dosing of praziquantel by height in sub-Saharan African adults.

Authors:  Chiquita A Palha De Sousa; Tracy Brigham; Bernard Chasekwa; Mduduzi N N Mbuya; James M Tielsch; Jean H Humphrey; Andrew J Prendergast
Journal:  Am J Trop Med Hyg       Date:  2014-03-03       Impact factor: 2.345

6.  Treatment of schistosomiasis in African infants and preschool-aged children: downward extension and biometric optimization of the current praziquantel dose pole.

Authors:  José C Sousa-Figueiredo; Martha Betson; J Russell Stothard
Journal:  Int Health       Date:  2012-06       Impact factor: 2.473

7.  From a weighing scale to a pole: a comparison of two different dosage strategies in mass treatment of Schistosomiasis haematobium.

Authors:  Per Nordin; Gabriele Poggensee; Sabina Mtweve; Ingela Krantz
Journal:  Glob Health Action       Date:  2014-12-03       Impact factor: 2.640

8.  The impact of an 8-year mass drug administration programme on prevalence, intensity and co-infections of soil-transmitted helminthiases in Burundi.

Authors:  Giuseppina Ortu; Mohamad Assoum; Udo Wittmann; Sarah Knowles; Michelle Clements; Onésime Ndayishimiye; Maria-Gloria Basáñez; Colleen Lau; Archie Clements; Alan Fenwick; Ricardo J Soares Magalhaes
Journal:  Parasit Vectors       Date:  2016-09-22       Impact factor: 3.876

9.  Field testing of the WHO dose pole for administration of praziquantel in the treatment of opisthorchiasis in Lao PDR.

Authors:  H Strandgaard; M V Johansen; A Montresor; N Ørnbjerg
Journal:  Trans R Soc Trop Med Hyg       Date:  2007-08-30       Impact factor: 2.184

10.  The Accuracy of Praziquantel Dose Poles for Mass Treatment of Schistosomiasis in School Girls in KwaZulu-Natal, South Africa.

Authors:  Marije Baan; Hashini Nilushika Galappaththi-Arachchige; Silindile Gagai; Christine G Aurlund; Birgitte J Vennervald; Myra Taylor; Lisette van Lieshout; Eyrun F Kjetland
Journal:  PLoS Negl Trop Dis       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.